Teva stock plummets 18% after rough quarter in US generic drug market
Governor Phil Murphy signed a Proclamation welcoming Teva … | Flickr
$40 million incentive lures global pharmaceutical giant to Parsippany
FDA approves Teva's generic EpiPen after yearslong delay
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva Pharmaceutical revenue by region 2018-2023 | Statista
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
Teva down as it reports lower sales and profit for 2018
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva recalls one lot of IDArubicin Hydrochloride Injection USP
Teva Pharm raises 2018 profit outlook, sees strong migraine drug launch | Reuters
Teva Pharmaceuticals on X: "Teva unveils new world class #pharma facility at #Mumbai R&D center: https://t.co/s0LOWejMwH https://t.co/jKjOxoAaGc" / X
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva Pharmaceutical: Earnings Trends and Recent Developments
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva Pharmaceuticals USA found liable in opioids case - Newsday
Teva agrees to pay $126 million to US hospitals over opioids | Reuters
Teva, one of the biggest generic makers, joins the the brand-name club
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
